2001 sccm/esicm/accp/ats/sis international sepsis definitions conference

…, D Angus, D Cook, J Cohen, SM Opal… - Critical care …, 2003 - journals.lww.com
Objective In 1991, the American College of Chest Physicians (ACCP) and the Society of
Critical Care Medicine (SCCM) convened a “Consensus Conference,” the goals of which were “…

Anti-inflammatory cytokines

SM Opal, VA DePalo - Chest, 2000 - Elsevier
The anti-inflammatory cytokines are a series of immunoregulatory molecules that control the
proinflammatory cytokine response. Cytokines act in concert with specific cytokine inhibitors …

[HTML][HTML] Sepsis and septic shock

RS Hotchkiss, LL Moldawer, SM Opal… - Nature reviews Disease …, 2016 - nature.com
For more than two decades, sepsis was defined as a microbial infection that produces fever (or
hypothermia), tachycardia, tachypnoea and blood leukocyte changes. Sepsis is now …

Recombinant human interleukin 1 receptor antagonist in the treatment of patients with sepsis syndrome: results from a randomized, double-blind, placebo-controlled …

…, SQ Simpson, RE Crowell, M Neidhart, D Stevens… - Jama, 1994 - jamanetwork.com
Objective. —To further define the safety and efficacy of recombinant human interleukin 1
receptor antagonist (rhIL-1ra) in the treatment of sepsis syndrome. Study Design. —Randomized…

Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock: 2012

…, A Rhodes, D Annane, H Gerlach, SM Opal… - Critical care …, 2013 - journals.lww.com
Objective: To provide an update to the “Surviving Sepsis Campaign Guidelines for
Management of Severe Sepsis and Septic Shock,” last published in 2008. Design: A consensus …

The third international consensus definitions for sepsis and septic shock (Sepsis-3)

…, MM Levy, JC Marshall, GS Martin, SM Opal… - Jama, 2016 - jamanetwork.com
Importance Definitions of sepsis and septic shock were last revised in 2001. Considerable
advances have since been made into the pathobiology (changes in organ function, …

Kidney disease: improving global outcomes (KDIGO) acute kidney injury work group. KDIGO clinical practice guideline for acute kidney injury

…, PT Murray, S Naicker, SM Opal… - Kidney international …, 2012 - experts.umn.edu
The 2011 Kidney Disease: Improving Global Outcomes (KDIGO) Clinical Practice Guideline
for Acute Kidney Injury (AKI) aims to assist practitioners caring for adults and children at risk …

High-dose antithrombin III in severe sepsis: a randomized controlled trial

…, H Heinrichs, F Schindel, M Juers, RC Bone, SM Opal… - Jama, 2001 - jamanetwork.com
ContextActivation of the coagulation system and depletion of endogenous anticoagulants
are frequently found in patients with severe sepsis and septic shock. Diffuse microthrombus …

[HTML][HTML] Treatment of septic shock with the tumor necrosis factor receptor: Fc fusion protein

CJ Fisher Jr, JM Agosti, SM Opal… - … England Journal of …, 1996 - Mass Medical Soc
Background A recombinant, soluble fusion protein that is a dimer of an extracellular portion
of the human tumor necrosis factor (TNF) receptor and the Fc portion of IgG1 (TNFR:Fc) …

Effect of eritoran, an antagonist of MD2-TLR4, on mortality in patients with severe sepsis: the ACCESS randomized trial

SM Opal, PF Laterre, B Francois, SP LaRosa… - Jama, 2013 - jamanetwork.com
Importance Eritoran is a synthetic lipid A antagonist that blocks lipopolysaccharide (LPS)
from binding at the cell surface MD2-TLR4 receptor. LPS is a major component of the outer …